Ruti Aga's Six Years: The Clinic on the Prescription Never Existed

The half marathon in China ended on a March night and Ruti Aga won it. The time is not on record anywhere official — no splits, no field depth, no wind reading. What got recorded was the sample. Then came the paper with a doctor's name on it, a registration number, and the address of a clinic that never existed.

On Thursday the Athletics Integrity Unit issued its statement. Six years. Two for the presence of methylprednisolone, four for tampering and for producing a forged prescription. Both counted from 10 September, the date she was provisionally suspended.

For a 32-year-old distance runner, six years is the end of a career. The return would come at 38, and in the depth of Ethiopian women's marathon running, a 38-year-old with a doping record on file does not enter the selection conversation.

Aga belongs to the generation that made 2:18 ordinary. Second in Berlin 2026 in about 2:18:34. The 2026 Tokyo Marathon title. Three second places at World Marathon Majors. This is the record of a tier, not of a promising newcomer — the tier from which Ethiopia sends one name forward every two or three years, and where even a 2:18 performer is not guaranteed a national team place.

The Chinese half marathon matters here because it belongs to the economic layer on which East African marathoners live between Majors. Appearance fee decent, race count low, injury exposure limited. That is the model. The same layer is now the AIU's highest-yield sampling ground. Money and testing are colliding in the same race, and the first sample out of that collision was Aga's.

Something has shifted in the AIU's road-running casebook over the past few years. The centre of the investigation used to be the sample. Now it is the paperwork. The first violation is detected, and the explanation offered afterwards becomes the second case. Aga's file is of that type: a two-year violation, and a four-year penalty for the document invented to explain it.

There is a mechanical detail of road-race testing that rarely makes the reports. The in-competition window for a road race opens at 23:59 the night before. An injection given days earlier can still be caught if residues remain. On the track the arithmetic works differently; on the road that arithmetic decides everything.

The early reports contained one technical error that has to be cleared up, because the whole case turns on it. Methylprednisolone was described as a prohibited steroid and reported as classed by WADA as performance-enhancing. It is not an anabolic steroid. It is a glucocorticoid, WADA Prohibited List class S9, and under the current List S9 is prohibited in-competition only — by injection, oral or rectal route. A therapeutic knee injection out of competition is entirely legal. It becomes a violation only when residues are present in-competition.

That technical point is the hinge of the entire file. The substance on which six years was imposed has no proven, measurable endurance benefit. The penalty fell on the paper, not on the drug.

Look at the arithmetic. Two years on presence, four on tampering. The Code's standard tampering sanction is four years, so that half is straightforward. The two-year half says more. Had the panel accepted a no-significant-fault argument on presence, the sanction could have been reduced, in some circumstances to a reprimand. The panel gave no such relief. And still it did not escalate the presence sanction — meaning it saw concealment intent but declined to carry it into the substance violation. The six years are built on exactly that reasoning.

The question is why she did not have a single document that was true. What she took is a separate matter.

This is not an isolated instance in Ethiopian road running. The pattern has been visible for years: world-class talent, local and informal medical structure. An athlete without a credentialed team physician, who does not know the TUE process, hides knee pain with the cheapest available tool. The cheapest tool is a glucocorticoid injection.

Three separate verifications failed in Aga's file. The clinic named on the prescription did not exist. The person who called himself a doctor was a family member with no medical registration. Asked about it, he said he had used an old prescription pad from a former workplace — and that workplace denied it flatly. Three places where the paper was lying.

This is where an old habit earns its keep. I keep an archive of everything nobody said on air — who employs whom, what the monthly salary is, where the funding comes from, and what sits in the medical file. The register began in Athens in 2026, after Anju Bobby George's 6.83m, because the mixed zone gave me the one fact no report carried. Twenty years on, the same habit says this: Aga's entire defence rested on the one thing she did not have, which was a real medical record.

After the 2026 Delhi Commonwealth Games I began writing a mandatory paragraph into every medal segment — who employs the athlete, who tests them, who signs off on what they swallow. In Aga's file the third question is blank. There was nobody signing.

With a real medical record, the argument was simple. Knee injury, injection date, competition date, and the gap between them. Under S9 the prohibition applies in-competition only, so the timing was the defence. Had the injection been given sufficiently before the race and been documented, there would have been no case at all. Had it been given late, the sanction would still have sat near two years and the tampering charge would never have been laid.

The forged prescription destroyed precisely the one defence that could have worked. That is the bitter truth of the file. The fraud raised the sentence — and the argument can be read backwards too: the fraud happened because the defence was thin, or the defence looked thin because the fraud happened. The AIU statement reads it the first way. So did the panel.

An appeal route exists — typically about twenty-one days from the reasoned decision — but it carries little value. A forged-prescription finding rests on documents, and document-based findings are the hardest to overturn.

Now the comfortable part.

The first comfortable reading is that this is a steroid case. It is not. The substance was an anti-inflammatory glucocorticoid, and for knee synovitis in distance runners that is standard practice. Anyone who queues this alongside anabolic-steroid cases is merging two different things.

The second comfortable reading is that six years against an African road runner is disproportionate enforcement. That is easy too. Had this been a substance case alone, the sanction would have been two years, perhaps less. Six years is the price of a document somebody made. The penalty fell on the paper, not on the drug.

Third, and least spoken: the knee. The most culpable party in this whole file is not a substance but an injury that was never properly treated. Before the medal there is a body keeping a secret. An injured marathoner has an economic reason to mask pain — appearance fees, contracts, the date of the next race. A glucocorticoid is the cheapest tool that silences pain for a few weeks and extends the injury by a few months. Aga did not hide the treatment; she tried to cover the absence of treatment with paper.

Fourth, what the statement does not say. Somebody around her advised this, or accepted the document. The AIU statement names only the family member. Whether an agent, a manager, a coach was investigated is not disclosed. Eleven seconds of silence taught me more than any question I ever asked, and in the AIU statement that silence sits exactly where an agent's name should have been.

China's label-race circuit is now a high-scrutiny zone. Large appearance budgets, deep East African fields, and AIU presence all land in the same race. Results from this tier will draw more questions, and the next time someone wins in China, the question will be her time or her prescription.

Aga's 2026 Tokyo title is not being taken from her, because the violation attaches to a March sample collected afterwards. But the result and the prize money from that March race are going, and the ranking points accrued after it as well.

The question is what a runner will have the next time her knee hurts — a real clinic, a real registration, a real date, or an old prescription pad.

A panel that hands down six years will catch the pad. It will not catch the compulsion that produced it.